Named on one round in the feed.
Since 2014-08-25
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Aspect Biosystems Bioengineered cellular medicines aimed at transforming disease treatment using bioprinting technology and regenerative medicine. | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2014-08-25 | [ PART ] |
No one else named on these rounds.